• Users Online: 6493
  • Home
  • Print this page
  • Email this page
This article has been cited by
1
Prin Rojanapongpun,Visanee Tantisevi
.2021;()31
[DOI]
2Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
Kai Man Xu,Ryan Cho,Toby Yiu Bong Chan
Clinical Ophthalmology.2022;Volume 16()2385
[DOI]
3Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer
Feng Gao,Xu Liu,Qing Zhao,Yingzhe Pan
Experimental and Therapeutic Medicine.2017;13(5)1912
[DOI]
4Bimatoprost: a unique compound that in its nonhydrolyzed form is a prostamide and hydrolyzed form has prostaglandin receptor activity, for glaucoma and cosmetic indications
E Randy Craven,Sultan A Alzuhairy
Expert Review of Ophthalmology.2014;9(3)159
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal